Xiamen Amoytop Biotech Co Ltd (688278.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100003RT3
Xiamen Amoytop Biotech Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.82 bn CNY | 3.70 bn CNY |
| Gross profit | 2.63 bn CNY | 3.70 bn CNY |
| Operating income | 970.74 m CNY | 1.25 bn CNY |
| EBIT | 931.67 m CNY | 1.18 bn CNY |
| Net income | 827.60 m CNY | 1.04 bn CNY |
| Diluted EPS – continuing operations | 2.03 CNY | 2.55 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Xiamen Amoytop Biotech Co Ltd
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
More stocks
- Angang Steel Co Ltd Class A (000898.SZ)
- Flywire Corp (FLYW)
- Harmonic Drive Systems Inc (6324.T)
- Nitto Boseki Co Ltd (3110.T)
- Henan Mingtai Al.Industrial Co Ltd (601677.SS)
- JOHN WILEY & SONS, INC. (WLY)
- Wistron NeWeb Corp (6285.TW)
- Amylyx Pharmaceuticals, Inc. (AMLX)
- Mr D I Y Group M Bhd (5296.KL)
- DNOW Inc. (DNOW)
- Beijing Sinnet Technology Co Ltd (300383.SZ)
- CECEP Solar Energy Co Ltd (000591.SZ)
Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.